Cargando…
Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: A Comprehensive Review, Part II
The development of immune checkpoint inhibitors (ICIs) has changed the treatment paradigm for cancer. The ICIs nivolumab, pembrolizumab, and cemiplimab target programmed cell death protein 1, and durvalumab, avelumab, and atezolizumab target programmed death ligand 1. Ipilimumab targets cytotoxic T...
Autores principales: | Bukamur, Hazim, Alkrekshi, Akram, Katz, Heather, Alsharedi, Mohamed, Shweihat, Yousef R., Munn, Nancy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389348/ https://www.ncbi.nlm.nih.gov/pubmed/34480197 http://dx.doi.org/10.14423/SMJ.0000000000001295 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab
por: Bukamur, Hazim, et al.
Publicado: (2020) -
Iatrogenic esophageal and tracheal perforation with tracheoesophageal fistula following emergency intubation
por: Alkrekshi, Akram, et al.
Publicado: (2020) -
The role and safety of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis and management of infected bronchogenic mediastinal cysts in adults
por: Bukamur, Hazim S., et al.
Publicado: (2018) -
Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life
por: Tariq, Anam, et al.
Publicado: (2018) -
Inconsistencies in Colonic Tattooing Practice: Differences in Reported and Actual Practices at a Tertiary Medical Center
por: Spaete, Joshua P., et al.
Publicado: (2019)